High-salt in addition to high-fat diet may enhance inflammation and fibrosis in liver steatosis induced by oxidative stress and dyslipidemia in mice

Lipids in Health and Disease

Volumn 14, Issue 1, 2015, Pages

  Uetake, Yuzaburo ^a   Ikeda, Hitoshi ^a,b   Irie, Rie ^c   Tejima, Kazuaki ^d   Matsui, Hiromitsu ^a   Ogura, Sayoko ^a,e   Wang, Hong ^a   Mu, Shengyu ^f   Hirohama, Daigoro ^a   Ando, Katsuyuki ^a   Sawamura, Tatsuya ^g,h   Yatomi, Yutaka ^b   Fujita, Toshiro ^a,f   Shimosawa, Tatsuo ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^c KAWASAKI MUNICIPAL HOSPITAL   (Japan)

^d Shinagawa ku   (Japan)

^e NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f UNIVERSITY OF TOKYO   (Japan)

^g NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^h SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Anti oxidant tempol; High salt diet induced oxidative stress; NADPH oxidase; Nonalcoholic fatty liver disease; Oxidative stress

Indexed keywords

ALANINE AMINOTRANSFERASE; FIBRONECTIN; HYALURONIC ACID; LOW DENSITY LIPOPROTEIN RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR 1; REACTIVE OXYGEN METABOLITE; TEMPOL; UNCLASSIFIED DRUG; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; OLR1 PROTEIN, MOUSE; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; SODIUM INTAKE; SUPEROXIDE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE EXACERBATION; DYSLIPIDEMIA; HEPATITIS; HIGH SODIUM INTAKE; LIPID DIET; LIPID STORAGE; LIVER FIBROSIS; LIVER INJURY; MALE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYSTOLIC BLOOD PRESSURE; ADVERSE EFFECTS; ANIMAL; BIOSYNTHESIS; CHEMISTRY; COMPLICATION; DRUG EFFECTS; FATTY LIVER; FIBROSIS; GENETICS; INFLAMMATION; KNOCKOUT MOUSE; LIVER; METABOLISM; PATHOLOGY; PHYSIOLOGY; SODIUM INTAKE; WESTERN BLOTTING;

MUS; MUS MUSCULUS;

ANIMALS; BLOTTING, WESTERN; DIET, HIGH-FAT; DYSLIPIDEMIAS; FATTY LIVER; FIBROSIS; INFLAMMATION; LIVER; MALE; MICE; MICE, KNOCKOUT; NADP; OXIDATIVE STRESS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SCAVENGER RECEPTORS, CLASS E; SODIUM, DIETARY; SUPEROXIDES;

EID: 84928663953     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/s12944-015-0002-9     Document Type: Article

References (36)

1. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2005;40:1387-95.
2. Nasrallah SM, Willis CEJ, Galambos JT. Hepatic morphology in obesity. Dig Dis Sci. 1981;26:325-7.
3. Braillon A, Capron JP, Hervé MA, Degott C, Quenum C. Liver in obesity. Gut. 1985;26:133-9.
4. Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity:anautopsy study with analysis of risk factors. Hepatology. 1990;12:1106-10.
5. Bacon BR, Farahvash MJ, Janney CG, Neuschwander-Tetri BA. Nonalcoholicsteatohepatitis: an expanded clinical entity. Gastroenterology. 1994;107:1103-9.
6. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, et al. Nonalcoholic fatty liver disease a feature of the metabolic syndrome. Diabetes. 2001;50:1844-50.
7. Willner IR, Waters B, Patil SR, Reuben A, Morelli J, Riely CA. Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease. Am J Gastroenterol. 2001;96:2957-61.
8. Musso G, Gambino R, De Michieli F, Cassader M, Rizzetto M, Durazzo M, et al. Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis. Hepatology. 2003;37:909-16.
9. Arima S, Uto H, Ibusuki R, Kumamoto R, Tanoue S, Mawatari S, et al. Hypertension exacerbates liver injury and hepatic fibrosis induced by a choline-deficient L-amino acid-defined diet in rats. Int J Mol Med. 2014;33:68-76.
10. Ekstedt M, Franzén LE, Mathiesen UL, Thorelius L, Holmqvist M, Bodemar G, et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology. 2006;44:865-73.
11. Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology. 2005;129:113-21.
12. Söderberg C, Stål P, Askling J, Glaumann H, Lindberg G, Marmur J, et al. Decreased survival of subjects with elevated liver function tests during a 28-year follow-up. Hepatology. 2010;51:595-602.
13. Browning JD, Horton JD. Molecular mediators of hepatic steatosis and liver injury. J Clin Invest. 2004;114:147-52.
14. Harrison SA, Torgerson S, Hayashi P, Ward J, Schenker S. Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis. Am J Gastroenterol. 2003;98:2485-90.
15. Kugelmas M, Hill DB, Vivian B, Marsano L, McClain CJ. Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E. Hepatology. 2003;38:413-9.
16. Kido M, Ando K, Onozato ML, Tojo A, Yoshikawa M, Ogita T, et al. Protective effect of dietary potassium against vascular injury in salt-sensitive hypertension. Hypertension. 2008;51:225-31.
17. Tian N, Moore RS, Phillips WE, Lin L, Braddy S, Pryor JS, et al. NADPH oxidase contributes to renal damage and dysfunction in Dahl salt-sensitive hypertension. Am J Physiol Regul Integr Comp Physiol. 2008;295:R1858-65.
18. Matsui H, Shimosawa T, Uetake Y, Wang H, Ogura S, Kaneko T, et al. Protective effect of potassium against the hypertensive cardiac dysfunction: association with reactive oxygen species reduction. Hypertension. 2006;48:225-31.
19. Fujita M, Ando K, Nagae A, Fujita T. Sympathoexcitation by oxidative stress in the brain mediates arterial pressure elevation in salt-sensitive hypertension. Hypertension. 2007;50:360-7.
20. Rosón MI, Della Penna SL, Cao G, Gorzalczany S, Pandolfo M, Cerrudo C, et al. High-sodium diet promotes a profibrogenic reaction in normal rat kidneys: effects of Tempol administration. J Nephrol. 2011;24:119-27.
21. Lenda DM, Boegehold MA. Effect of a high-salt diet on oxidant enzyme activity in skeletal muscle microcirculation. Am J Physiol Heart Circ Physiol. 2002;282:H395-402.
22. Eichhorn B, Muller G, Leuner A, Sawamura T, Ravens U, Morawietz H. Impaired vascular function in small resistance arteries of LOX-1 overexpressing mice on high-fat diet. Cardiovasc Res. 2009;82:493-502.
23. Sawamura T, Kume N, Aoyama T, Moriwaki H, Hoshikawa H, Aiba Y, et al. An endothelial receptor for oxidized low-density lipoprotein. Nature. 1997;386:73-7.
24. Inoue K, Arai Y, Kurihara H, Kita T, Sawamura T. Overexpression of lectin-like oxidized low-density lipoprotein receptor-1 induces intramyocardial vasculopathy in apolipoprotein E-null mice. Circ Res. 2005;97:176-84.
25. Harats D, Kurihara H, Belloni P, Oakley H, Ziober A, Ackley D, et al. Targeting gene expression to the vascular wall in transgenic mice using the murine preproendothelin-1 promoter. J Clin Invest. 1995;95:1335-44.
26. Mehta JL, Sanada N, Hu CP, Chen J, Dandapat A, Sugawara F, et al. Deletion of LOX-1 reduces atherogenesis in LDLR knockout mice fed high cholesterol diet. Circ Res. 2007;100:1634-42.
27. Piedrahita JA, Zhang SH, Hagaman JR, Oliver PM, Maeda N. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc Natl Acad Sci U S A. 1992;89:4471-5.
28. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Non-alcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999;94:2467-74.
29. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Nonalcoholic Steatohepatitis Clinical Research Network: Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313-21.
30. Mu S, Shimosawa T, Ogura S, Wang H, Uetake Y, Kawakami-Mori F, et al. Epigenetic modulation of the renal β-adrenergic-WNK4 pathway in salt-sensitive hypertension. Nat Med. 2011;17:573-80.
31. Tejima K, Arai M, Ikeda H, Tomiya T, Yanase M, Inoue Y, et al. Ischemic preconditioning protects hepatocytes via reactive oxygen species derived from Kupffer cells in rats. Gastroenterology. 2004;127:1488-96.
32. Jones OM, Rees M, John TG, Bygrave S, Plant G. Biopsy of resectable colorectal liver metastases causes tumour dissemination and adversely affects survival after liver resection. Br J Surg. 2005;92:1165-8.
33. Ratziu V, Charlotte F, Heurtier A, Gombert S, Giral P, Bruckert E, et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology. 2005;128:1898-906.
34. - production by a non-phagocytic NAD(P)H oxidase causes oxidant injury. J Biol Chem. 2001;276:29251-6.
35. Ushio-Fukai M, Griendling KK, Becker PL, Hilenski L, Halleran S, Alexander RW. Epidermal growth factor receptor transactivation by angiogensin II requires reactive oxygen species in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2001;21:489-95.
36. Gregg D, Rauscher FM, Goldschmidt-Clermont PJ. Rac regulates cardiovascular superoxide through diverse molecular interactions: more than binary GTP switch. Am J Physiol Cell Physiol. 2003;285:C723-34.